Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Therative’s ThermaClear acne clearing device now available at Ulta stores
According to Therative, ThermaClear is safe on all skin types and tones and does not cause the drying, irritation or skin hyper pigmentation often associated with many topical
According to Therative, ThermaClear is safe on all skin types and tones and does not cause the drying, irritation or skin hyper pigmentation often associated with many topical
These results are substantially in line with management expectations. They reflect budgeted sales and marketing initiatives to promote the Previstage GCC Colorectal Cancer Staging Test and further product
Progenics Pharmaceuticals, a biopharmaceutical company, has reported a net loss of $14.6m, or $0.49 per share, for the fourth quarter of 2008, compared to a net loss of
Persistent activation of the Akt pathway has been found to play an important role in oncogenesis and chemo- and radiation-resistance and to be responsible for cancer cell proliferation,
MLR-1023 was discovered and developed internally using Melior’s indications discovery platform, theraTRACE. Andrew Reaume, president and CEO of Melior, said: “We are delighted to have been given the
Cytori offered the securities in this transaction pursuant to an effective shelf registration statement. The funds will be used for sales and marketing activities related to the commercialization
According to the company, this novel test incorporates 10 biomarkers, two of which are proprietary, along with a proprietary algorithm to help physicians diagnose patients with irritable bowel
In 2008, Voboril, 66, retired as chairman of Greatbatch, Inc., where he served as chief executive officer from 1990 to 2006. During his tenure at Greatbatch, he led
AOS Medical Center, Glendale, California, purchased a KODAK DIRECTVIEW DR 3500 System and a PACS workstation for its orthopedic practice through Merry X-Ray, an authorized distributor. Doctors Community
Genentech, a biotechnology company, and US-based Biogen Idec have announced that a Phase III study of Rituxan plus mycophenolate mofetil and corticosteroids in patients with lupus nephritis did